Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 11/2016

29-07-2016 | Review

EQ-5D in Central and Eastern Europe: 2000–2015

Auteurs: Fanni Rencz, László Gulácsi, Michael Drummond, Dominik Golicki, Valentina Prevolnik Rupel, Judit Simon, Elly A. Stolk, Valentin Brodszky, Petra Baji, Jakub Závada, Guenka Petrova, Alexandru Rotar, Márta Péntek

Gepubliceerd in: Quality of Life Research | Uitgave 11/2016

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Objective

Cost per quality-adjusted life year data are required for reimbursement decisions in many Central and Eastern European (CEE) countries. EQ-5D is by far the most commonly used instrument to generate utility values in CEE. This study aims to systematically review the literature on EQ-5D from eight CEE countries.

Methods

An electronic database search was performed up to 1 July 2015 to identify original EQ-5D studies from the countries of interest. We analysed the use of EQ-5D with respect to clinical areas, methodological rigor, population norms and value sets.

Results

We identified 143 studies providing 152 country-specific results with a total sample size of 81,619: Austria (n = 11), Bulgaria (n = 6), Czech Republic (n = 18), Hungary (n = 47), Poland (n = 51), Romania (n = 2), Slovakia (n = 3) and Slovenia (n = 14). Cardiovascular (21 %), neurologic (17 %), musculoskeletal (15 %) and endocrine, nutritional and metabolic diseases (13 %) were the most frequently studied clinical areas. Overall, 112 (78 %) of the studies reported EQ VAS results and 86 (60 %) EQ-5D index scores, of which 27 (31 %) did not specify the applied tariff. Hungary, Poland and Slovenia have population norms. Poland and Slovenia also have a national value set.

Conclusions

Increasing use of EQ-5D is observed throughout CEE. The spread of health technology assessment activities in countries seems to be reflected in the number of EQ-5D studies. However, improvement in informed use and methodological quality of reporting is needed. In jurisdictions where no national value set is available, in order to ensure comparability we recommend to apply the most frequently used UK tariff. Regional collaboration between CEE countries should be strengthened.
vorige artikel A review of empirical research related to the use of small quantitative samples in clinical outcome scale development
volgende artikel The health-related quality of life of ankylosing spondylitis patients assessed by SF-36: a systematic review and meta-analysis
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
Gulacsi, L., Rotar, A. M., Niewada, M., Loblova, O., Rencz, F., Petrova, G., et al. (2014). Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria. The European Journal of Health Economics, 15(Suppl 1), S13–25.PubMedCrossRef
2.
Az Emberi Eroforrások Minisztériuma szakmai irányelve az egészség-gazdaságtani elemzések készítéséhez (hatályos: 2013.03.01-től) (2013). Egészségügyi Közlöny (3), 1314–1334.
3.
4.
5.
6.
7.
Assembly of the Health Insurance Institute of Slovenia. Rules on the Classification of Medicine on the List (Official Gazette of RS, no. 110/2010, dated 12/31/2010 no. 5779) 2010.
8.
9.
Gulacsi, L., Rencz, F., Pentek, M., Brodszky, V., Lopert, R., Hever, N. V., et al. (2014). Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries. The European Journal of Health Economics, 15(Suppl 1), S27–34.PubMedCrossRef
10.
The Act on Reimbursement of Medicines, Foodstuffs Intended for Particular Nutritional Purposes and Medical Devices from 12th of May, 2011 (Journal of Laws, No. 122, item 696).
11.
Baji, P., Brodszky, V., Rencz, F., Boncz, I., Gulácsi, L., & Péntek, M. (2015). Health status of the Hungarian population between 2000–2010. Orvosi Hetilap, 156(50.), 2035–2044.
12.
Szende, A., Leidy, N. K., Ståhl, E., & Svensson, K. (2009). Estimating health utilities in patients with asthma and COPD: Evidence on the performance of EQ-5D and SF-6D. Quality of Life Research, 18(2), 267–272.PubMedCrossRef
13.
Yordanova, S., Petkova, V., Petrova, G., Dimitrov, M., Naseva, E., Dimitrova, M., et al. (2014). Comparison of health-related quality-of-life measurement instruments in diabetic patients. Biotechnology and Biotechnological Equipment, 28(4), 769–774.PubMedPubMedCentralCrossRef
14.
Hever, N. V., Pentek, M., Ballo, A., Gulacsi, L., Baji, P., Brodszky, V., et al. (2015). Health related quality of life in patients with bladder cancer: a cross-sectional survey and validation study of the hungarian version of the bladder cancer index. Pathology & Oncology Research, 21(3), 619–627.CrossRef
15.
Felder-Puig, R., Frey, E., Sonnleithner, G., Feeny, D., Gadner, H., Barr, R. D., et al. (2000). German cross-cultural adaptation of the Health Utilities Index and its application to a sample of childhood cancer survivors. European Journal of Pediatrics, 159(4), 283–288.PubMedCrossRef
16.
Rencz, F., Brodszky, V., Pentek, M., Bereczki, D., & Gulacsi, L. (2015). Health state utilities for migraine based on attack frequency: a time trade-off study. Neurological Sciences, 36(2), 197–202.PubMedCrossRef
17.
Obaidi, L. A., & Mahlich, J. (2015). A potential gender bias in assessing quality of life—a standard gamble experiment among university students. ClinicoEconomics and outcomes research, 7, 227–233.PubMedPubMedCentral
18.
Inotai, A., Rojkovich, B., Fulop, A., Jaszay, E., Agh, T., & Meszaros, A. (2012). Health-related quality of life and utility in patients receiving biological and non-biological treatments in rheumatoid arthritis. Rheumatology International, 32(4), 963–969.PubMedCrossRef
19.
Tillinger, W., Mittermaier, C., Lochs, H., & Moser, G. (1999). Health-related quality of life in patients with Crohn’s disease: influence of surgical operation–a prospective trial. Digestive Diseases and Sciences, 44(5), 932–938.PubMedCrossRef
20.
21.
Siegel, J. E., Torrance, G. W., Russell, L. B., Luce, B. R., Weinstein, M. C., & Gold, M. R. (1997). Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine. Pharmacoeconomics, 11(2), 159–168.PubMedCrossRef
22.
Методологични указания за представяните документи за оценка на ефикасността, безопасността и фармакоикономическите показатели на лекарствени продукти при кандидатстване за включване в Позитивен лекарствен списък. (Приети на Заседание на НСЦРЛП – Протокол № 114/23.04.2015 г.) (2015).
23.
Coretti, S., Ruggeri, M., & McNamee, P. (2014). The minimum clinically important difference for EQ-5D index: a critical review. Expert Review of Pharmacoeconomics & Outcomes Research, 14(2), 221–233.CrossRef
24.
Tordrup, D., Mossman, J., & Kanavos, P. (2014). Responsiveness of the EQ-5D to clinical change: is the patient experience adequately represented? International Journal of Technology Assessment in Health Care, 30(1), 10–19.PubMedCrossRef
25.
Payakachat, N., Ali, M. M., & Tilford, J. M. (2015). Can The EQ-5D Detect Meaningful Change? A Systematic Review. Pharmacoeconomics, 33(11), 1137–1154.PubMed
26.
Xie, F., Gaebel, K., Perampaladas, K., Doble, B., & Pullenayegum, E. (2014). Comparing EQ-5D valuation studies: a systematic review and methodological reporting checklist. Medical Decision Making, 34(1), 8–20.PubMedCrossRef
27.
Janssen, M. F., Lubetkin, E. I., Sekhobo, J. P., & Pickard, A. S. (2011). The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus. Diabetic Medicine, 28(4), 395–413.PubMedCrossRef
28.
Pickard, A. S., Wilke, C., Jung, E., Patel, S., Stavem, K., & Lee, T. A. (2008). Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respiratory Medicine, 102(4), 519–536.PubMedCrossRef
29.
Pickard, A. S., Wilke, C. T., Lin, H. W., & Lloyd, A. (2007). Health utilities using the EQ-5D in studies of cancer. Pharmacoeconomics, 25(5), 365–384.PubMedCrossRef
30.
Davis, S., & Wailoo, A. (2013). A review of the psychometric performance of the EQ-5D in people with urinary incontinence. Health and Quality of Life Outcomes, 11, 20.PubMedPubMedCentralCrossRef
31.
Dyer, M. T., Goldsmith, K. A., Sharples, L. S., & Buxton, M. J. (2010). A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health and Quality of Life Outcomes, 8, 13.PubMedPubMedCentralCrossRef
32.
Hounsome, N., Orrell, M., & Edwards, R. T. (2011). EQ-5D as a quality of life measure in people with dementia and their carers: evidence and key issues. Value Health, 14(2), 390–399.PubMedCrossRef
33.
Moller, A. H., Erntoft, S., Vinding, G. R., & Jemec, G. B. (2015). A systematic literature review to compare quality of life in psoriasis with other chronic diseases using EQ-5D-derived utility values. Patient Related Outcome Measures, 6, 167–177.PubMedPubMedCentral
34.
Noyes, J., & Edwards, R. T. (2011). EQ-5D for the assessment of health-related quality of life and resource allocation in children: a systematic methodological review. Value Health, 14(8), 1117–1129.PubMedCrossRef
35.
Papaioannou, D., Brazier, J., & Parry, G. (2011). How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? A systematic review. Value Health, 14(6), 907–920.PubMedPubMedCentralCrossRef
36.
Derrett, S., Black, J., & Herbison, G. P. (2009). Outcome after injury-a systematic literature search of studies using the EQ-5D. Journal of Trauma, 67(4), 883–890.PubMedCrossRef
37.
EuroQol Group. (1990). EuroQol–a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef
38.
39.
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727–1736.PubMedPubMedCentralCrossRef
40.
Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., et al. (2013). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Quality of Life Research, 22(7), 1717–1727.PubMedCrossRef
41.
Ravens-Sieberer, U., Wille, N., Badia, X., Bonsel, G., Burstrom, K., Cavrini, G., et al. (2010). Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study. Quality of Life Research, 19(6), 887–897.PubMedPubMedCentralCrossRef
42.
Wille, N., Badia, X., Bonsel, G., Burstrom, K., Cavrini, G., Devlin, N., et al. (2010). Development of the EQ-5D-Y: a child-friendly version of the EQ-5D. Quality of Life Research, 19(6), 875–886.PubMedPubMedCentralCrossRef
43.
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ, 339, b2535.PubMedPubMedCentralCrossRef
44.
45.
De Smedt, D., Clays, E., Doyle, F., Kotseva, K., Prugger, C., Pajak, A., et al. (2013). Validity and reliability of three commonly used quality of life measures in a large European population of coronary heart disease patients. International Journal of Cardiology, 167(5), 2294–2299.PubMedCrossRef
46.
De Smedt, D., Clays, E., Hofer, S., Oldridge, N., Kotseva, K., Maggioni, A. P., et al. (2016). Validity and reliability of the HeartQoL questionnaire in a large sample of stable coronary patients: The EUROASPIRE IV Study of the European Society of Cardiology. European Journal of Preventive Cardiology, 23(7), 714–721.PubMedCrossRef
47.
Barbist, M. T., Renn, D., Noisternig, B., Rumpold, G., & Hofer, S. (2008). How do medical students value health on the EQ-5D? Evaluation of hypothetical health states compared to the general population. Health and Quality of Life Outcomes, 6, 111.PubMedPubMedCentralCrossRef
48.
Borgstrom, F., Lekander, I., Ivergard, M., Strom, O., Svedbom, A., Alekna, V., et al. (2013). The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)—Quality of life during the first 4 months after fracture. Osteoporosis International, 24(3), 811–823.PubMedCrossRef
49.
Cichocki, M., Quehenberger, V., Zeiler, M., Adamcik, T., Manousek, M., Stamm, T., et al. (2015). Effectiveness of a low-threshold physical activity intervention in residential aged care—results of a randomized controlled trial. Clinical Interventions in Aging, 10, 885–895.PubMedPubMedCentralCrossRef
50.
Gamper, G., Willeit, M., Sterz, F., Herkner, H., Zoufaly, A., Hornik, K., et al. (2004). Life after death: posttraumatic stress disorder in survivors of cardiac arrest–prevalence, associated factors, and the influence of sedation and analgesia. Critical Care Medicine, 32(2), 378–383.PubMedCrossRef
51.
Ghosh, P., Djordjevic, M., Schistek, R., Baier, R., & Unger, F. (2003). Does gender affect outcome of cardiac surgery in octogenarians? Asian Cardiovascular and Thoracic Annals, 11(1), 28–32.PubMedCrossRef
52.
Hofer, S., Kullich, W., Graninger, U., Wonisch, M., Gassner, A., Klicpera, M., et al. (2009). Cardiac rehabilitation in Austria: long term health-related quality of life outcomes. Health and Quality of Life Outcomes, 7, 99.PubMedPubMedCentralCrossRef
53.
Kobelt, G., Berg, J., Lindgren, P., Plesnilla, C., Baumhackl, U., Berger, T., et al. (2006). Costs and quality of life of multiple sclerosis in Austria. The European Journal of Health Economics, 7(Suppl 2), S14–23.PubMedCrossRef
54.
Prugger, M., & Berger, T. (2013). Assessing the long-term clinical benefit of prolonged-release fampridine tablets in a real-world setting: a review of 67 cases. Patient Related Outcome Measures, 4, 75–85.PubMedPubMedCentral
55.
Quehenberger, V., Cichocki, M., & Krajic, K. (2014). Sustainable effects of a low-threshold physical activity intervention on health-related quality of life in residential aged care. Clinical Interventions in Aging, 9, 1853–1864.PubMedPubMedCentralCrossRef
56.
Winter, Y., Von Campenhausen, S., Gasser, J., Seppi, K., Reese, J. P., Pfeiffer, K. P., et al. (2010). Social and clinical determinants of quality of life in Parkinson’s disease in Austria: A cohort study. Journal of Neurology, 257(4), 638–645.PubMedCrossRef
57.
Ganzinger, U., Badelt, C., Vass, K., Strasser-Fuchs, S., Fazekas, F., Berger, T., et al. (2004). Krankheitskosten der multiplen Sklerose in Österreich. Der Nervenarzt, 75(10), 1000–1006.PubMedCrossRef
58.
Naseva, E., Bratovanova, S., Stoicheval, M., & Gardeva, M. (2015). Health related quality of life—A comparison of EQ-5D index calculation methods. General Medicine, 16(3), 3–8.
59.
Vankova, D., Kerekovska, A., Kostadinova, T., & Todorova, L. (2015). Researching health-related quality of life at a community level: results from a population survey conducted in Burgas, Bulgaria. Health Promot Int. 2015 March 16 pii:dav016 [Epub ahead of print].
60.
Iskrov, G. G., Stefanov, R. S., Lopez-Bastida, J., Linertova, R., Oliva-Moreno, J., & Serrano-Aguilar, P. (2015). Economic burden and health-related quality of life of patients with cystic fibrosis in Bulgaria. Folia Medica (Plovdiv), 57(1), 56–64.
61.
Abrahámová, J. (2007). Quality of life improvement in patients with bone metastases treated by clodronate. Praktický lékař, 87(11), 648–654.
62.
Bulkova, V., Fiala, M., Havranek, S., Simek, J., Sknouril, L., Januska, J., et al. (2014). Improvement in quality of life after catheter ablation for paroxysmal versus long-standing persistent atrial fibrillation: a prospective study with 3-year follow-up. Journal of the American Heart Association, 3(4), e000881.PubMedPubMedCentralCrossRef
63.
Fiala, M., Wichterle, D., Bulkova, V., Sknouril, L., Nevralova, R., Toman, O., et al. (2014). A prospective evaluation of haemodynamics, functional status, and quality of life after radiofrequency catheter ablation of long-standing persistent atrial fibrillation. Europace, 16(1), 15–25.PubMedCrossRef
64.
Haman, L., Dostalova, H., & Parizek, P. (2012). Catheter ablation for atrial fibrillation—Single center experience. Cor et Vasa, 54(6), e369–e374.CrossRef
65.
Horak, P., Skacelova, M., Hejduk, K., Smrzova, A., & Pavelka, K. (2013). Abatacept and its use in the treatment of rheumatoid arthritis (RA) in the Czech Republic-data from the ATTRA registry. Clinical Rheumatology, 32(10), 1451–1458.PubMedCrossRef
66.
Špirudová, L., & Nol, J. (2014). Quality of life of patients after lung transplantation. Kontakt, 16(1), 12–20.CrossRef
67.
Židková, A., Chytra, I., Šestáková, B., Kasal, E., & Týblová, I. (2012). Quality of life one year after discharge from ICU. Anaesthesiology & Intensive Medicine, 23(2), 75–81.
68.
Kala, P., Tretina, M., Poloczek, M., Ondrasek, J., Malik, P., Pokorny, P., et al. (2013). Quality of life after transcatheter aortic valve implantation and surgical replacement in high-risk elderly patients. Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, 157(1), 75–80.CrossRef
69.
Sauerland, S., Weiner, S., Hausler, E., Dolezalova, K., Angrisani, L., Noguera, C. M., et al. (2009). Validity of the Czech, German, Italian, and Spanish version of the Moorehead-Ardelt II questionnaire in patients with morbid obesity. Obesity Facts, 2(Suppl 1), 57–62.PubMedCrossRef
70.
Dolezal, T., Vocelka, M., & Klimes, J. (2012). Clinical effectiveness of 8% capsaicin dermal patch in neuropathic pain—Noninterventional real-life clinical study in Czech Republic. Bolest, 15(1), 28–32.
71.
Otruba, P. (2015). Neuritogen and diabetic neuropathic pain. Bolest, 18(1), 29–35.
72.
Slovacek, L., Slovackova, B., Blazek, M., & Jebavy, L. (2007). Quality of life in patients with multiple myeloma and malignant lymphoma undergoing autologous progenitor stem cell transplantation: The effect of selected psychosocial and health aspects on quality of life: A retrospective analysis. Reports of Practical Oncology and Radiotherapy, 12(2), 101–108.CrossRef
73.
Slovacek, L., Slovackova, B., & Chovanec, V. (2007). The effect of femoral and popliteal percutaneous transluminal balloon angioplasty on patients’ quality of life. Sao Paulo Medical Journal, 125(4), 250–252.PubMedCrossRef
74.
Slovacek, L., Slovackova, B., Pavlik, V., & Slanska, I. (2009). Sibutramine - Its impact on health-related quality of life and depression among adult obese non-diabetic patients. Bratislava Medical Journal, 110(8), 496–499.PubMed
75.
Slovacek, L., Slovackova, B., Slanska, I., Petera, J., & Priester, P. (2010). Quality of life and depression among metastatic breast cancer patients. Medical Oncology, 27(3), 958–959.PubMedCrossRef
76.
Zavada, J., Uher, M., Jarkovsky, J., Vencovsky, J., & Pavelka, K. (2014). Assessment of utility score EQ-D and estimating the Cost-utility of the first year of treatment by TNF inhibitors in a cohort of patients with Rheumatoid Arthritis during-results from the Czech biologics registry ATTRA. Česká Revmatologie, 22(1), 10–16.
77.
Balogh, O., Pentek, M., Gulacsi, L., Farkas, K., Jarai, Z., Landi, A., et al. (2013). Quality of life and burden of disease in peripheral arterial disease: a study among Hungarian patients. Orvosi Hetilap, 154(12), 464–470.PubMedCrossRef
78.
Brodszky, V., Péntek, M., Komoly, S., Bereczki, D., Embey-Isztin, D., Torzsa, P., et al. (2015). Quality of life of patients with non-diabetic peripheral neuropathic pain; results from a cross-sectional survey in general practices in Hungary. Ideggyogyaszati Szemle, 68(9–10), 325–330.PubMedCrossRef
79.
Deli, G., Balas, I., Doczi, T., Janszky, J., Karadi, K., Aschermann, Z., et al. (2015). Deep brain stimulation can preserve working status in Parkinson’s disease. Parkinsons Disease, 2015, 936865.
80.
Minier, T., Pentek, M., Brodszky, V., Ecseki, A., Karpati, K., Polgar, A., et al. (2010). Cost-of-illness of patients with systemic sclerosis in a tertiary care centre. Rheumatology (Oxford), 49(10), 1920–1928.CrossRef
81.
Péntek, M., Brodszky, V., Érsek, K., Jelics, N., Jermendy, G., Winkler, G., et al. (2009). Health status and quality of life of insulin treated diabetic adults—cross-sectional survey of 480 patients attending general practitioners and diabetology centres. Diabetologia Hungarica, 17(3), 249–260.
82.
Pentek, M., Brodszky, V., Gulacsi, A. L., Hajdu, O., van Exel, J., Brouwer, W., et al. (2014). Subjective expectations regarding length and health-related quality of life in Hungary: results from an empirical investigation. Health Expectations, 17(5), 696–709.PubMedCrossRef
83.
Péntek, M., Herczegfalvi, Á., Molnár, M. J., Szőnyi, L., Kosztolányi, G., Pfliegler, G., et al. (2016). Disease burden of Duchenne muscular dystrophy patients and their caregivers. Ideggyogyaszati Szemle, 69(5–6), 183–193.
84.
Pentek, M., Kosztolanyi, G., Melegh, B., Halasz, A., Pogany, G., Baji, P., et al. (2014). Health related quality of life and disease burden of patients with cystic fibrosis and their caregivers: Results of the European BURQOL-RD survey in Hungary. Orvosi Hetilap, 155(42), 1673–1684.PubMedCrossRef
85.
Péntek, M., Licker-Fóris, E., Lovas, K., Kaló, Z., Tóth, M., Tulassay, Z., et al. (2003). Assessment of quality of life in postmenopausal women with osteoporosis—A comparative study on the Hungarian adaptations of EuroQoL and Nottingham Health Profile. Ca & Csont, 6(4), 158–163.
86.
Rencz, F., Brodszky, V., Pentek, M., Balogh, O., Remenyik, E., Szegedi, A., et al. (2014). Disease burden of psoriasis associated with psoriatic arthritis in Hungary. Orvosi Hetilap, 155(48), 1913–1921.PubMedCrossRef
87.
Vokó, Z., Inotai, A., Horváth, C., Bors, K., Speer, G., & Kaló, Z. (2013). Quality of life in patients with osteoporosis in Hungary. Lege Artis Medicinae KID, 3(4), 35–41.
88.
Agh, T., Inotai, A., & Meszaros, A. (2011). Factors associated with medication adherence in patients with chronic obstructive pulmonary disease. Respiration, 82(4), 328–334.PubMedCrossRef
89.
Bosnyak, E., Herceg, M., Pal, E., Aschermann, Z., Janszky, J., Kesmarki, I., et al. (2014). Are branded and generic extended-release ropinirole formulations equally efficacious? A rater-blinded, switch-over, multicenter study. Parkinsons Disease, 2014, 158353.
90.
Deli, G., Balas, I., Komoly, S., Doczi, T., Janszky, J., Illes, Z., et al. (2012). Treatment of dystonia by deep brain stimulation: a summary of 40 cases. Ideggyogyaszati Szemle, 65(7–8), 249–260.PubMed
91.
Ersek, K., Kovacs, T., Wimo, A., Karpati, K., Brodszky, V., Pentek, M., et al. (2010). Costs of dementia in Hungary. The Journal of Nutrition, Health & Aging, 14(8), 633–639.CrossRef
92.
Gombos, T., Kertesz, K., Csikos, A., Soderhamn, U., Soderhamn, O., & Prohaszka, Z. (2008). Nutritional form for the elderly is a reliable and valid instrument for the determination of undernutrition risk, and it is associated with health-related quality of life. Nutrition Research, 28(2), 59–65.PubMedCrossRef
93.
Hanko, B., Kazmer, M., Kumli, P., Hragyel, Z., Samu, A., Vincze, Z., et al. (2007). Self-reported medication and lifestyle adherence in Hungarian patients with Type 2 diabetes. Pharmacy World & Science, 29(2), 58–66.CrossRef
94.
Herceg, M., Nagy, F., Pal, E., Janszky, J., Kesmarky, I., Komoly, S., et al. (2012). Pramipexole may be an effective treatment option in essential tremor. Clinical Neuropharmacology, 35(2), 73–76.PubMedCrossRef
95.
Heredi, E., Rencz, F., Balogh, O., Gulacsi, L., Herszenyi, K., Hollo, P., et al. (2014). Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary. The European Journal of Health Economics, 15(Suppl 1), S111–119.PubMedCrossRef
96.
Horvath, K., Aschermann, Z., Acs, P., Deli, G., Janszky, J., Karadi, K., et al. (2014). Test-retest validity of Parkinson’s disease sleep scale 2nd version (PDSS-2). Journal of Parkinson’s Disease, 4(4), 687–691.PubMed
97.
Kiraly, E., & Gondos, T. (2012). Cardiovascular diseases and the health-related quality of life after total hip replacement. Journal of Clinical Nursing, 21(19–20), 2843–2850.PubMedCrossRef
98.
Kovacs, C., Pecze, M., Tihanyi, A., Kovacs, L., Balogh, S., & Bender, T. (2012). The effect of sulphurous water in patients with osteoarthritis of hand. Double-blind, randomized, controlled follow-up study. Clinical Rheumatology, 31(10), 1437–1442.PubMedCrossRef
99.
Kovacs, N., Aschermann, Z., Acs, P., Bosnyak, E., Deli, G., Janszky, J., et al. (2014). The impact of levodopa-carbidopa intestinal gel on health-related quality of life in Parkinson’s disease. Ideggyogyaszati Szemle, 67(7–8), 245–250.PubMed
100.
Kulisch, A., Benko, A., Bergmann, A., Gyarmati, N., Horvath, H., Kranicz, A., et al. (2014). Evaluation of the effect of Lake Heviz thermal mineral water in patients with osteoarthritis of the knee: A randomized, controlled, single-blind, follow-up study. European Journal of Physical Rehabilation Medicine, 50(4), 373–381.
101.
Pentek, M., Gulacsi, L., Majoros, A., Piroth, C., Rubliczky, L., Boszormenyi Nagy, G., et al. (2012). Health related quality of life and productivity of women with overactive bladder. Orvosi Hetilap, 153(27), 1068–1076.PubMedCrossRef
102.
Pentek, M., Gulacsi, L., Rojkovich, B., Brodszky, V., van Exel, J., & Brouwer, W. B. (2014). Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists. The European Journal of Health Economics, 15(Suppl 1), S83–92.PubMedCrossRef
103.
Pentek, M., Harangozo, J., Egerhazi, A., Kelemen, O., Gulacsi, L., Baji, P., et al. (2012). Health related quality of life and disease burden of patients with schizophrenia in Hungary. Psychiatria Hungarica, 27(1), 4–17.PubMed
104.
Rencz, F., Kovacs, A., Brodszky, V., Gulacsi, L., Nemeth, Z., Nagy, G. J., et al. (2015). Cost of illness of medically treated benign prostatic hyperplasia in Hungary. International Urology and Nephrology, 47(8), 1241–1249.PubMedCrossRef
105.
Tamas, G., Gulacsi, L., Bereczki, D., Baji, P., Takats, A., Brodszky, V., et al. (2014). Quality of life and costs in Parkinson’s disease: a cross sectional study in Hungary. PLoS One, 9(9), e107704.PubMedPubMedCentralCrossRef
106.
Tefner, I. K., Gaal, R., Koroknai, A., Rathonyi, A., Gati, T., Monduk, P., et al. (2013). The effect of Neydharting mud-pack therapy on knee osteoarthritis: a randomized, controlled, double-blind follow-up pilot study. Rheumatology International, 33(10), 2569–2576.PubMedCrossRef
107.
Tefner, I. K., Kovacs, C., Gaal, R., Koroknai, A., Horvath, R., Badruddin, R. M., et al. (2015). The effect of balneotherapy on chronic shoulder pain. A randomized, controlled, single-blind follow-up trial. A pilot study. Clinical Rheumatology, 34(6), 1097–1108.PubMedCrossRef
108.
Tefner, I. K., Nemeth, A., Laszlofi, A., Kis, T., Gyetvai, G., & Bender, T. (2012). The effect of spa therapy in chronic low back pain: a randomized controlled, single-blind, follow-up study. Rheumatology International, 32(10), 3163–3169.PubMedCrossRef
109.
Bokor, M., & Szentesi, A. (2010). The effect of Stalevo-dosing on quality of life of Parkinsonian patients with wearing-off. Ideggyogyaszati Szemle, 63(7–8), 247–251.PubMed
110.
Brodszky, V., Pentek, M., Blint, P. V., Geher, P., Hajdu, O., Hodinka, L., et al. (2010). Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: Results from a cross-sectional survey. Scandinavian Journal of Rheumatology, 39(4), 303–309.PubMedCrossRef
111.
Klivenyi, P., & Vecsei, L. (2008). The use of Stalevo in Hungary for patients with Parkinson disease and its effect on the quality of life. Ideggyogyaszati Szemle, 61(1–2), 42–48.PubMed
112.
Meszaros, A., & Vincze, Z. (2003). Analysis of quality of life among patients with bronchial asthma or rheumatoid arthritis. Orvosi Hetilap, 144(9), 423–427.PubMed
113.
Pentek, M., Bereczki, D., Gulacsi, L., Mikudina, B., Aranyi, Z., Juhos, V., et al. (2013). Survey of adults with epilepsy in Hungary: Health related quality of life and costs. Ideggyogyaszati Szemle, 66(7–8), 251–261.PubMed
114.
Pentek, M., Gulacsi, L., Rozsa, C., Simo, M., Iljicsov, A., Komoly, S., et al. (2012). Health status and costs of ambulatory patients with multiple sclerosis in Hungary. Ideggyogyaszati Szemle, 65(9–10), 316–324.PubMed
115.
Pentek, M., Szekanecz, Z., Czirjak, L., Poor, G., Rojkovich, B., Polgar, A., et al. (2008). Impact of disease progression on health status, quality of life and costs in rheumatoid arthritis in Hungary. Orvosi Hetilap, 149(16), 733–741.PubMedCrossRef
116.
Szende, A., & Molnar, L. (2001). Inequalities in health status and inequity in the delivery of health care in Hungary. Archives of Hellenic Medicine, 18(2), 169–179.
117.
Szende, A., & Nemeth, R. (2003). Health-related quality of life of the Hungarian population. Orvosi Hetilap, 144(34), 1667–1674.PubMed
118.
Voko, Z., Nemeth, R., Nagyjanosi, L., Jermendy, G., Winkler, G., Hidvegi, T., et al. (2014). Mapping the Nottingham health profile onto the preference-based EuroQol-5D instrument for patients with diabetes. Value in Health Regional Issues, 4, 31–36.CrossRef
119.
Banaszkiewicz, M., Wawrzonkowska, I., & Andruszkiewicz, A. (2014). The health behaviours and their selected predictors and quality of women’s life in postmenopausal period on the example of the patients of Multi-Municipal Hospital dr E. Warmiński in Bydgoszcz. Przedsiębiorczość i Zarządzanie, 12(1), 263–279.
120.
Borowiak, E., & Barylska, A. (2007). Problems of seniors in House of Day’s Stay—challenge for nurse. Problemy Pielęgniarstwa, 15(1), 13–19.
121.
Farkowski, M. M., Pytkowski, M., Maciag, A., Golicki, D., Wood, K. A., Kowalik, I., et al. (2014). Gender-related differences in outcomes and resource utilization in patients undergoing radiofrequency ablation of supraventricular tachycardia: results from Patients’ Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT Study. Europace, 16(12), 1821–1827.PubMedCrossRef
122.
Golicki, D., Jakubczyk, M., Niewada, M., Wrona, W., & Busschbach, J. J. (2010). Valuation of EQ-5D health states in Poland: first TTO-based social value set in Central and Eastern Europe. Value in Health, 13(2), 289–297.PubMedCrossRef
123.
Jarosławska, B., & Błaszczyk, B. (2012). Quality of life of patients after ischamic stroke treated in hospital area of the administrative unit. Studia Medyczne, 26(2), 19–29.
124.
Kołtowski, L., Drohomirecka, A., Palczewski, M., & Cichoń, R. (2011). Short-term improvement of patients’ quality of life after coronary artery bypass grafting—A prospective single-center study based on the EQ-5D assessment tool. Advances in Clinical and Experimental Medicine, 20(4), 447–453.
125.
Kwaśniewska, M., Bielecki, W., & Drygas, W. (2004). Sociodemographic and clinical determinants of quality of life in urban population of Poland. Central European Journal of Public Health, 12(2), 63–68.PubMed
126.
Kwaśniewska, M., & Drygas, W. (2005). Quality of life in patients with risk factors of coronary heart disease. Przeglad Lekarski, 62(9), 863–870.PubMed
127.
Pasek, J., Kwiatek, P., Pasek, T., Szajkowski, S., Szewc, A., & Sieroń, A. (2012). Application of magnetic field and visible light in the treatment of low back pain and sciatic neuralgia. Aktualn Neurol, 12(1), 65–68.
128.
Pasek, J., Szajkowski, S., Suszyński, K., Wiaderkiewicz, J., & Kwiek, S. (2009). The quality of life at patients with the extrapyramidal system diseases after stereotactic surgery and rehabilitation. Annales Academiae Medicae Silesiensis, 63(6), 32–39.
129.
Puto, G., Ocetkiewicz, T., & Zawisza, K. (2008). Influence of depression and cognitive function on subjective assessment of quality of life in patients over 80 years old with myocardial ischemia. Gerontologia Polska, 15(3), 90–96.
130.
Skowron, A., & Turska, W. (2008). Assessment of the quality of life among patient witha arterial hypertension and diabetes type 2. Farmacja Polska, 64(17), 745–796.
131.
Uchmanowicz, I., Jankowska, B., Panaszek, B., & Fal, A. M. (2010). The impact of socio-demographic factors on health related quality of life (HRQoL) of patients with asthma. Współczesna Alergologia Info, 5(2), 57–65.
132.
van Hout, B., Janssen, M. F., Feng, Y. S., Kohlmann, T., Busschbach, J., Golicki, D., et al. (2012). Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value in Health, 15(5), 708–715.PubMedCrossRef
133.
Woźniak, J., Królicka, A., Pokryszko-Draga, A., Włodarczyk, I., Dudek, K., & Włodarczyk, K. (2012). Assessment of overall efficiency, daily living activities and quality of life in elderly adults with suspected dementia. Psychogeriatria Polska, 9(4), 149–160.
134.
Zuraw, W., Golicki, D., Jurecka, A., & Tylki-Szymanska, A. (2011). Quality of life among polish Fabry patients - a cross-sectional study quality of life among polish Fabry patients. Central European Journal of Medicine, 6(6), 741–749.
135.
Borowiak, E., & Kostka, T. (2004). Predictors of quality of life in older people living at home and in institutions. Aging Clinical and Experimental Research, 16(3), 212–220.PubMedCrossRef
136.
Deskur-Smielecka, E., Borowicz-Bienkowska, S., Brychcy, A., Wilk, M., Przywarska, I., & Dylewicz, P. (2009). Why patients after acute coronary syndromes do not participate in an early outpatient rehabilitation programme? Kardiologia Polska, 67(6), 632–638.PubMed
137.
Dudzinska, M., Tarach, J. S., Zwolak, A., Kurowska, M., Malicka, J., Smolen, A., et al. (2013). Type 2 diabetes mellitus in relation to place of residence: evaluation of selected aspects of socio-demographic status, course of diabetes and quality of life–a cross-sectional study. Annals of Agricultural and Environmental Medicine, 20(4), 869–874.PubMed
138.
Golicki, D., & Niewada, M. (2015). General population reference values for 3-level EQ-5D (EQ-5D-3L) questionnaire in Poland. Polskie Archiwum Medycyny Wewnętrznej, 125(1–2), 18–26.PubMed
139.
Kaleta, D., & Jegier, A. (2004). Leisure time physical activity and subjective health state in adults. Polskie Archiwum Medycyny Wewnętrznej, 111(5), 537–545.PubMed
140.
Kleczynski, P., Bagienski, M., Sorysz, D., Rzeszutko, L., Trebacz, J., Tomala, M., et al. (2014). Short- and intermediate-term improvement of patient quality of life after transcatheter aortic valve implantation: a single-centre study. Kardiologia Polska, 72(7), 612–616.PubMed
141.
Koltowski, L., Koltowska-Haggstrom, M., Filipiak, K. J., Kochman, J., Golicki, D., Pietrasik, A., et al. (2014). Quality of life in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention–radial versus femoral access (from the OCEAN RACE Trial). American Journal of Cardiology, 114(4), 516–521.PubMedCrossRef
142.
Machaczka, M., Kampe Bjorkvall, C., Wieremiejczyk, J., Paucar Arce, M., Myhr-Eriksson, K., Klimkowska, M., et al. (2015). Impact of imiglucerase supply shortage on clinical and laboratory parameters in norrbottnian patients with Gaucher disease type 3. Archivum immunolgiae et therapiae experimentalis, 63(1), 65–71.CrossRef
143.
Maselbas, W., Chabik, G., & Czlonkowska, A. (2010). Persistence with treatment in patients with Wilson disease. Neurologia i Neurochirurgia Polska, 44(3), 260–263.PubMedCrossRef
144.
Matusiak, L., Bieniek, A., & Szepietowski, J. C. (2010). Psychophysical aspects of hidradenitis suppurativa. Acta Dermato Venereologica, 90(3), 264–268.PubMedCrossRef
145.
Pierzchala, K., Adamczyk-Sowa, M., Dobrakowski, P., Kubicka-Baczyk, K., Niedziela, N., & Sowa, P. (2015). Demographic characteristics of MS patients in Poland’s upper Silesia region. International Journal of Neuroscience, 125(5), 344–351.PubMedCrossRef
146.
Szyca, R., Zimmermann, A., & Leksowski, K. (2010). Influence of low-molecular-weight heparin on the life quality of patients after intravascular medical procedures in comparison to patients who were treated with oral anticoagulants. Polski Merkuriusz Lekarski, 29(171), 157–161.PubMed
147.
Boros, P. W., & Lubinski, W. (2012). Health state and the quality of life in patients with chronic obstructive pulmonary disease in Poland: A study using the EQ-5D questionnaire. Polskie Archiwum Medycyny Wewnętrznej, 122(3), 73–81.PubMed
148.
Borowiak, E., & Kostka, T. (2006). Influence of chronic cardiovascular disease and hospitalisation due to this disease on quality of life of community-dwelling elderly. Quality of Life Research, 15(7), 1281–1289.PubMedCrossRef
149.
Gierat-Haponiuk, K., Haponiuk, I., Szalewska, D., Chojnicki, M., Jaworski, R., Niedoszytko, P., et al. (2015). Effect of complex cardiac rehabilitation on physical activity and quality of life during long-term follow-up after surgical correction of congenital heart disease. Kardiologia Polska, 73(4), 267–273.PubMedCrossRef
150.
Golicki, D., Dudzinska, M., Zwolak, A., & Tarach, J. S. (2015). Quality of life in patients with type 2 diabetes in Poland - comparison with the general population using the EQ-5D questionnaire. Advances in Clinical and Experimental Medicine, 24(1), 139–146.PubMedCrossRef
151.
Golicki, D., Niewada, M., Jakubczyk, M., Wrona, W., & Hermanowski, T. (2010). Self-assessed health status in Poland: EQ-5D findings from the Polish valuation study. Polskie Archiwum Medycyny Wewnętrznej, 120(7–8), 276–281.PubMed
152.
Grabowska, P., Targowski, T., & Jahnz-Rozyk, K. (2006). Evaluation of quality of life and knowledge about tobacco smoking toxicity among patients hospitalized in Department of Pneumonology. Przeglad Lekarski, 63(10), 1071–1074.PubMed
153.
Jegier, A., Szmigielska, K., Bilinska, M., Brodowski, L., Galaszek, M., Mrozek, P., et al. (2009). Health-related quality of life in patients with coronary heart disease after residential vs ambulatory cardiac rehabilitation. Circulation Journal, 73(3), 476–483.PubMedCrossRef
154.
Kaleta, D., & Jegier, A. (2005). Ambulatory cardiac rehabilitation and selected quality of life parameters among men with coronary artery disease. Przeglad Lekarski, 62(7), 657–660.PubMed
155.
Kostka, J., Borowiak, E., & Kostka, T. (2014). Nutritional status and quality of life in different populations of older people in Poland. European Journal of Clinical Nutrition, 68(11), 1210–1215.PubMedCrossRef
156.
Mitosek-Szewczyk, K., Kulakowska, A., Bartosik-Psujek, H., Hozejowski, R., Drozdowski, W., & Stelmasiak, Z. (2014). Quality of life in Polish patients with multiple sclerosis. Advances in Medical Sciences, 59(1), 34–38.PubMedCrossRef
157.
Noone, D., O’Mahony, B., van Dijk, J. P., & Prihodova, L. (2013). A survey of the outcome of prophylaxis, on-demand treatment or combined treatment in 18-35-year old men with severe haemophilia in six countries. Haemophilia, 19(1), 44–50.PubMedCrossRef
158.
Nowakowska-Glab, A., & Maniecka-Bryla, I. (2011). Relation between occupation and health related quality of life of pregnant women. Medycyna Pracy, 62(6), 601–607.PubMed
159.
Nowakowska-Glab, A., Maniecka-Bryla, I., Wilczynski, J., & Nowakowska, D. (2010). Evaluation of antenatal quality of life of hospitalized women with the use of Mother-Generated Index–pilot study. Ginekologia Polska, 81(7), 521–527.PubMed
160.
Salabura, B., Klimek-Poskorz, E., & Sokol, B. (2005). The quality of life in patients after myocardial infraction treated with coronary angioplasty. Fizjoterapia, 13(3), 33–41.
161.
Wrobel, M. P., Szymborska-Kajanek, A., Wystrychowski, G., Biniszkiewicz, T., Sieron-Stoltny, K., Sieron, A., et al. (2008). Impact of low frequency pulsed magnetic fields on pain intensity, quality of life and sleep disturbances in patients with painful diabetic polyneuropathy. Diabetes and Metabolism, 34(4), 349–354.PubMedCrossRef
162.
Golicki, D., Niewada, M., Buczek, J., Karlińska, A., Kobayashi, A., Janssen, M. F., et al. (2015). Validity of EQ-5D-5L in stroke. Quality of Life Research, 24(4), 845–850.PubMedCrossRef
163.
Kostka, T., & Bogus, K. (2007). Independent contribution of overweight/obesity and physical inactivity to lower health-related quality of life in community-dwelling older subjects. Zeitschrift für Gerontologie und Geriatrie, 40(1), 43–51.PubMedCrossRef
164.
Kostka, T., & Jachimowicz, V. (2010). Relationship of quality of life to dispositional optimism, health locus of control and self-efficacy in older subjects living in different environments. Quality of Life Research, 19(3), 351–361.PubMedCrossRef
165.
Łabuz-Roszak, B., Kubicka-Bączyk, K., Pierzchała, K., Horyniecki, M., Machowska-Majchrzak, A., Augustyńska-Mutryn, D., et al. (2013). Quality of life in multiple sclerosis—Association with clinical features, fatigue and depressive syndrome. Psychiatria Polska, 47(3), 433–441.PubMed
166.
167.
Golicki, D., Niewada, M., Karlinska, A., Buczek, J., Kobayashi, A., Janssen, M. F., et al. (2015). Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients. Quality of Life Research, 24(6), 1555–1563.PubMedCrossRef
168.
Khoshab, H. A., & Sloboda, T. (2015). Minimal access spinal technologies (MAST) fusion procedures for the treatment of the degenerative lumbar spine (a part of multicentral prospective study). Case Report. Neuroendocrinology Letters, 36(3), 231–235.PubMed
169.
Klepanec, A., Mistrik, M., Altaner, C., Valachovicova, M., Olejarova, I., Slysko, R., et al. (2012). No difference in intra-arterial and intramuscular delivery of autologous bone marrow cells in patients with advanced critical limb ischemia. Cell Transplantation, 21(9), 1909–1918.PubMedCrossRef
170.
Rosa, J., Vanuga, P., Noskovic, M., & Ritomsky, A. (2004). Profile of patients presenting with postmenopausal osteoporosis treated with raloxifene. Osteologicky Bulletin, 9(1), 18–21.
171.
Dernovsek, M. Z., Prevolnik Rupel, V., Rebolj, M., & Tavcar, R. (2001). Quality of life and treatment costs in schizophrenic outpatients, treated with depot neuroleptics. European Psychiatry, 16(8), 474–482.PubMedCrossRef
172.
Kersnik, J. (2000). Observational study of home visits in Slovene general practice: patient characteristics, practice characteristics and health care utilization. Family Practice, 17(5), 389–393.PubMedCrossRef
173.
Klemenc-Ketis, Z. (2011). Disability in patients with chronic non-specific low back pain: validation of the Slovene version of the Oswestry Disability Index. Zdravstveno Varstvo, 50(2), 87–94.
174.
Klemenc-Ketis, Z., & Kersnik, J. (2014). Health seeking behaviour in general population with psychological symptoms. Psychiatria Danubina, 26(2), 181–186.PubMed
175.
Klemenc-Ketis, Z., Kersnik, J., Eder, K., & Colaric, D. (2011). Factors associated with health-related quality of life among university students. Srpski Arhiv za Celokupno Lekarstvo, 139(3–4), 197–202.PubMedCrossRef
176.
Klemenc-Ketis, Z., Smogavec, M., Softic, N., & Kersnik, J. (2011). Health-related quality of life: a population based study from Slovenia. Central European Journal of Public Health, 19(1), 7–12.PubMed
177.
Korosec Jagodic, H., Jagodic, K., & Podbregar, M. (2006). Long-term outcome and quality of life of patients treated in surgical intensive care: A comparison between sepsis and trauma. Critical Care, 10(5), R134.PubMedPubMedCentralCrossRef
178.
Pavsic, K., Pelicon, K., Ledinek, A. H., & Sega, S. (2015). Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients. Clinical Neurology and Neurosurgery, 139, 35–40.PubMedCrossRef
179.
Prevolnik Rupel, V., & Ogorevc, M. (2014). Use of the EQ-5D instrument and value scale in comparing health states of patients in four health care programs among health care providers. Value in Health Regional Issues, 4, 95–99.CrossRef
180.
Zelko, E., Svab, I., & Pavlic, D. R. (2015). Quality of life and patient satisfaction with family practice care in a Roma Population with chronic conditions in northeast Slovenia. Zdravstveno Varstvo, 54(1), 18–26.PubMed
181.
Prevolnik Rupel, V., Marušič, D., & S, K. (2005). Quality of life of the coronary club members. Zdravstveno Varstvo, (44), 151–160.
182.
Rebolj, M., & Prevolnik Rupel, V. (2001). Socioeconomic inequalities in health of the Slovenian population measured by the EQ-5D instrument. In A. Norinder, P. KM, & P. Roos (Eds.), Proceedings of the 18th of the EuroQol Group, 6 th –7th September, 2001, Copanhagen, Denmark (pp. 199–213).
183.
Borowiak, E., & Kostka, T. (2003). Physical activity of elderly inhabitants of Lodz. Polish Journal of Sports Medicine, 19(4), 139–146.
184.
Golicki, D., Niewada, M., Hout, B. V., Janssen, M. F., & Pickard, A. S. (2014). Interim EQ-5D-5L value set for Poland: First crosswalk value set in central and eastern Europe. Value in Health Regional Issues, 4(1), 19–23.CrossRef
185.
Prevolnik Rupel, V., & Ogorevc, M. (2012). The EQ-5D health states value set for Slovenia. Zdravstveno Varstvo, 51(2), 128–140.
186.
Gulacsi, L., Boncz, I., & Drummond, M. (2004). Issues for countries considering introducing the “fourth hurdle”: the case of Hungary. International Journal of Technology Assessment in Health Care, 20(3), 337–341.PubMedCrossRef
187.
Gulacsi, L., Brodszky, V., Pentek, M., Varga, S., Vas, G., & Boncz, I. (2009). History of health technology assessment in Hungary. International Journal of Technology Assessment in Health Care, 25(Suppl 1), 120–126.PubMedCrossRef
188.
Nizankowski, R., & Wilk, N. (2009). From idealistic rookies to a regional leader: The history of health technology assessment in Poland. International Journal of Technology Assessment in Health Care, 25(Suppl 1), 156–162.PubMedCrossRef
189.
Prosser, L. A., Lamarand, K., Gebremariam, A., & Wittenberg, E. (2015). Measuring family HRQoL spillover effects using direct health utility assessment. Medical Decision Making, 35(1), 81–93.PubMedPubMedCentralCrossRef
190.
Wittenberg, E., & Prosser, L. A. (2013). Disutility of illness for caregivers and families: A systematic review of the literature. Pharmacoeconomics, 31(6), 489–500.PubMedPubMedCentralCrossRef
191.
Wittenberg, E., Ritter, G. A., & Prosser, L. A. (2013). Evidence of spillover of illness among household members: EQ-5D scores from a US sample. Medical Decision Making, 33(2), 235–243.PubMedCrossRef
192.
Tilford, J. M., & Payakachat, N. (2015). Progress in measuring family spillover effects for economic evaluations. Expert Rev Pharmacoecon Outcomes Res, 15(2), 195–198.PubMedCrossRef
193.
Brooks, R. (2012). The EuroQol Group After 25 Years. Berlin: Springer.
194.
Rabin, R., Oemar, M., & Oppe, M. (2011). EQ-5D-3L user guide: Basic information on how to use the EQ-5D-3L instrument. Rotterdam: EuroQol Group.
195.
Kolasa, K., Schubert, S., Manca, A., & Hermanowski, T. (2011). A review of Health Technology Assessment (HTA) recommendations for drug therapies issued between 2007 and 2009 and their impact on policymaking processes in Poland. Health Policy, 102(2–3), 145–151.PubMedCrossRef
196.
Kolasa, K., & Wasiak, R. (2012). Health technology assessment in Poland and Scotland: comparison of process and decisions. International Journal of Technology Assessment in Health Care, 28(1), 70–76.PubMedCrossRef
197.
Niewada, M., Polkowska, M., Jakubczyk, M., & Golicki, D. (2013). What influences recommendations issued by the agency for health technology assessment in Poland? A glimpse into decision makers’ preferences. Value in Health Regional Issues, 2(2), 267–272.CrossRef
198.
Knies, S., Evers, S. M., Candel, M. J., Severens, J. L., & Ament, A. J. (2009). Utilities of the EQ-5D: transferable or not? Pharmacoeconomics, 27(9), 767–779.PubMedCrossRef
199.
Knott, R. J., Black, N., Hollingsworth, B., & Lorgelly, P. K. (2016). Response-Scale Heterogeneity in the EQ-5D. Health Econ. doi:10.​1002/​hec.​3313.
200.
Gunther, O. H., Roick, C., Angermeyer, M. C., & Konig, H. H. (2008). The responsiveness of EQ-5D utility scores in patients with depression: A comparison with instruments measuring quality of life, psychopathology and social functioning. Journal of Affective Disorders, 105(1–3), 81–91.PubMedCrossRef
201.
Heijink, R., van Baal, P., Oppe, M., Koolman, X., & Westert, G. (2011). Decomposing cross-country differences in quality adjusted life expectancy: The impact of value sets. Population Health Metrics, 9(1), 17.PubMedPubMedCentralCrossRef
202.
Matter-Walstra, K., Klingbiel, D., Szucs, T., Pestalozzi, B. C., & Schwenkglenks, M. (2014). Using the EuroQol EQ-5D in Swiss cancer patients, which value set should be applied? Pharmacoeconomics, 32(6), 591–599.PubMedCrossRef
203.
Norman, R., Cronin, P., Viney, R., King, M., Street, D., & Ratcliffe, J. (2009). International comparisons in valuing EQ-5D health states: A review and analysis. Value in Health, 12(8), 1194–1200.PubMedCrossRef
204.
Stark, R. G., Reitmeir, P., Leidl, R., & Konig, H. H. (2010). Validity, reliability, and responsiveness of the EQ-5D in inflammatory bowel disease in Germany. Inflammatory Bowel Diseases, 16(1), 42–51.PubMedCrossRef
205.
Bernert, S., Fernandez, A., Haro, J. M., Konig, H. H., Alonso, J., Vilagut, G., et al. (2009). Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries. Value in Health, 12(5), 750–758.PubMedCrossRef
206.
Greiner, W., Weijnen, T., Nieuwenhuizen, M., Oppe, S., Badia, X., Busschbach, J., et al. (2003). A single European currency for EQ-5D health states. Results from a six-country study. The European Journal of Health Economics, 4(3), 222–231.PubMedCrossRef
Metagegevens
Titel
EQ-5D in Central and Eastern Europe: 2000–2015
Auteurs
Fanni Rencz
László Gulácsi
Michael Drummond
Dominik Golicki
Valentina Prevolnik Rupel
Judit Simon
Elly A. Stolk
Valentin Brodszky
Petra Baji
Jakub Závada
Guenka Petrova
Alexandru Rotar
Márta Péntek
Publicatiedatum
29-07-2016
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 11/2016
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-016-1375-6

Andere artikelen Uitgave 11/2016

Quality of Life Research 11/2016 Naar de uitgave

OriginalPaper

The benefits of personal strengths in mental health of stressed students: A longitudinal investigation

OriginalPaper

The development and acceptability of symptom management quality improvement reports based on patient-reported data: an overview of methods used in PROSSES

OriginalPaper

The joint association of self-rated health and diabetes status on 14-year mortality in elderly men and women

OriginalPaper

Individuals’ quality of life linked to major life events, perceived social support, and personality traits

Review

A review of empirical research related to the use of small quantitative samples in clinical outcome scale development

OriginalPaper

Prospective associations of objectively assessed physical activity at different intensities with subjective well-being in older adults